X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (31) 31
Book / eBook (4) 4
Publication (4) 4
Newspaper Article (3) 3
Dissertation (2) 2
Book Chapter (1) 1
Magazine Article (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (11) 11
index medicus (10) 10
female (7) 7
male (7) 7
adult (6) 6
middle aged (6) 6
rheumatology (6) 6
antiphospholipid syndrome (5) 5
abridged index medicus (4) 4
analysis (4) 4
association (4) 4
catastrophic antiphospholipid syndrome (4) 4
rheumatoid arthritis (4) 4
risk factors (4) 4
rituximab (4) 4
allergy and immunology (3) 3
antiphospholipid syndrome - therapy (3) 3
arthritis (3) 3
death (3) 3
immunology (3) 3
management (3) 3
medical and health sciences (3) 3
medicin och hälsovetenskap (3) 3
medicine, general & internal (3) 3
mortality (3) 3
patients (3) 3
rheumatoid factor (3) 3
risk (3) 3
safety (3) 3
adolescent (2) 2
aged (2) 2
all-cause mortality (2) 2
antibodies, monoclonal, murine-derived - therapeutic use (2) 2
antiphospholipid syndrome - blood (2) 2
antiphospholipid syndrome - diagnosis (2) 2
antiphospholipid syndrome - physiopathology (2) 2
argentina (2) 2
cardiovascular disease (2) 2
care and treatment (2) 2
child-mortality (2) 2
children (2) 2
clinical medicine (2) 2
countries (2) 2
criteria (2) 2
diagnosis (2) 2
double-blind method (2) 2
drug dosages (2) 2
early arthritis (2) 2
estimating adult mortality (2) 2
health (2) 2
health risk assessment (2) 2
hiv (2) 2
immunoglobulins, intravenous - therapeutic use (2) 2
infant (2) 2
internal medicine (2) 2
klinisk medicin (2) 2
life expectancy (2) 2
lipoproteins (2) 2
medicine & public health (2) 2
monoclonal antibodies (2) 2
myocardial-infarction (2) 2
pcsk9 (2) 2
pediatric (2) 2
pharmaceutical industry (2) 2
plasma exchange (2) 2
polymorphism (2) 2
population (2) 2
recurrence (2) 2
refractory (2) 2
registries (2) 2
severity of illness index (2) 2
treatment outcome (2) 2
trends (2) 2
undifferentiated arthritis (2) 2
young adult (2) 2
[sdv.mhep.csc]life sciences [q-bio]/human health and pathology/cardiology and cardiovascular system (1) 1
[sdv.mhep]life sciences [q-bio]/human health and pathology (1) 1
[sdv]life sciences [q-bio] (1) 1
aacr2 (1) 1
abstracts (1) 1
acquired immune deficiency syndrome--aids (1) 1
activated protein c resistance - blood (1) 1
activated protein c resistance - diagnosis (1) 1
activated protein c resistance - epidemiology (1) 1
activated protein c resistance - genetics (1) 1
acute coronary syndrome (1) 1
acute coronary syndrome - blood (1) 1
acute coronary syndrome - complications (1) 1
acute coronary syndrome - drug therapy (1) 1
acute coronary syndromes (1) 1
adalimumab - administration & dosage (1) 1
adalimumab - adverse effects (1) 1
adalimumab - therapeutic use (1) 1
administration, oral (1) 1
adults (1) 1
age (1) 1
aged, 80 and over (1) 1
agricultural basins (1) 1
alleles (1) 1
allelomorphism (1) 1
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2017, Volume 390, Issue 10093, pp. 457 - 468
Summary Background Tofacitinib is an oral Janus kinase inhibitor for the treatment of rheumatoid arthritis. The Oral Rheumatoid Arthritis triaL (ORAL) Strategy... 
Internal Medicine | MEDICINE, GENERAL & INTERNAL | MODIFYING ANTIRHEUMATIC DRUGS | NECROSIS-FACTOR | PLACEBO | JANUS KINASE INHIBITOR | INADEQUATE RESPONSE | LONG-TERM SAFETY | PLUS METHOTREXATE | AMERICAN-COLLEGE | OPEN-LABEL | COMBINATION | Antirheumatic Agents - administration & dosage | Humans | Middle Aged | Male | Methotrexate - therapeutic use | Adalimumab - adverse effects | Arthritis, Rheumatoid - drug therapy | Pyrroles - administration & dosage | Antirheumatic Agents - adverse effects | Pyrroles - adverse effects | Adult | Female | Drug Therapy, Combination | Pyrroles - therapeutic use | Antirheumatic Agents - therapeutic use | Severity of Illness Index | Piperidines - administration & dosage | Double-Blind Method | Drug Administration Schedule | Administration, Oral | Pyrimidines - administration & dosage | Treatment Outcome | Methotrexate - adverse effects | Adalimumab - therapeutic use | Adalimumab - administration & dosage | Piperidines - therapeutic use | Pyrimidines - therapeutic use | Piperidines - adverse effects | Pyrimidines - adverse effects | Methotrexate - administration & dosage | Rheumatoid factor | Care and treatment | Analysis | Clinical trials | Arthritis | Pharmaceutical industry | Methotrexate | Rheumatology | Patients | Studies | Rheumatoid arthritis | Monoclonal antibodies | Rheumatism | TNF inhibitors | Janus kinase | Tumor necrosis factor-TNF | Safety | Drug therapy | Drug dosages
Journal Article
Autoimmunity Reviews, ISSN 1568-9972, 2011, Volume 10, Issue 11, pp. 664 - 668
Abstract The catastrophic variant of the antiphospholipid syndrome (APS) is the most severe form of APS with acute multiple organ involvement and small vessel... 
Allergy and Immunology | Refractory | Anticardiolipin antobodies | Defibrotide | Rituximab | Eculizumab | Catastrophic antiphospholipid syndrome | Lupus anticoagulant | MORTALITY | SERIES | ANTIBODY | DEATH | IMMUNOLOGY | Anticoagulants (Medicine) | Antiphospholipid syndrome
Journal Article
Autoimmunity Reviews, ISSN 1568-9972, 2013, Volume 12, Issue 11, pp. 1085 - 1090
Abstract The catastrophic variant of the antiphospholipid syndrome (APS) is characterized by thrombosis in multiple organs developing over a short period of... 
Allergy and Immunology | Refractory | Anti-CD20 | Rituximab | Catastrophic antiphospholipid syndrome | CELL DEPLETION THERAPY | SYSTEMIC LUPUS ERYTHAEMATOSUS | MANAGEMENT | INTERNATIONAL CONSENSUS STATEMENT | IMMUNOLOGY | CLASSIFICATION CRITERIA | Analysis | Antiphospholipid syndrome
Journal Article
Science of the Total Environment, ISSN 0048-9697, 01/2020, Volume 701, p. 134601
Glyphosate-based herbicides are the most commonly used herbicide worldwide. Although glyphosate is known to be toxic to aquatic organisms, it can also have... 
South America | Picocyanobacteria | Freshwater lakes | Glyphosate/AMPA | Spatial structure | Land use/land cover
Journal Article
Journal Article
by Dicker, Daniel and Nguyen, Trang Huyen and Nguyen, Ha Thu and Nguyen, Grant and Nguyen, Long Hoang and Nguyen, Huong Thanh and Nguyen, Michele and Abate, Kalkidan Hassen and Abate, Degu and Abay, Solomon M and Abbafati, Cristiana and Abbasi, Nooshin and Abbastabar, Hedayat and Abd-Allah, Foad and Abdela, Jemal and Abdelalim, Ahmed and Abdel-Rahman, Omar and Abdi, Alireza and Abdollahpour, Ibrahim and Abdulkader, Rizwan Suliankatchi and Abdurahman, Ahmed Abdulahi and Abebe, Haftom Temesgen and Abebe, Zegeye and Abebe, Molla and Abebo, Teshome Abuka and Aboyans, Victor and Abraha, Haftom Niguse and Abrham, Aklilu Roba and Abu-Raddad, Laith Jamal and Abu-Rmeileh, Niveen ME and Accrombessi, Manfred Mario Kokou and Acharya, Pawan and Adebayo, Oladimeji M and Adedeji, Isaac Akinkunmi and Adedoyin, Rufus Adesoji and Adekanmbi, Victor and Adetokunboh, Olatunji O and Adhena, Beyene Meressa and Adhikari, Tara Ballav and Adib, Mina G and Adou, Arsène Kouablan and Adsuar, Jose C and Afarideh, Mohsen and Afshin, Ashkan and Agarwal, Gina and Aggarwal, Rakesh and Aghayan, Sargis Aghasi and Agrawal, Sutapa and Agrawal, Anurag and Ahmadi, Mehdi and Ahmadi, Alireza and Ahmadieh, Hamid and Ahmed, Muktar Beshir and Ahmed, Mohamed Lemine Cheikh brahim and Ahmed, Sayem and Aichour, Ibtihel and Aichour, Miloud Taki Eddine and Aichour, Amani Nidhal and Akanda, Ali S and Akbari, Mohammad Esmaeil and Akibu, Mohammed and Akinyemi, Rufus Olusola and Akinyemiju, Tomi and Akseer, Nadia and Alahdab, Fares and Al-Aly, Ziyad and Alam, Khurshid and Alebel, Animut and Aleman, Alicia V and Alene, Kefyalew Addis and Al-Eyadhy, Ayman and Ali, Raghib and Alijanzadeh, Mehran and Alizadeh-Navaei, Reza and Aljunid, Syed Mohamed and Alkerwi, Ala'a and Alla, François and Allebeck, Peter and Allen, Christine A and Alonso, Jordi and Al-Raddadi, Rajaa M and Alsharif, Ubai and Altirkawi, Khalid and Alvis-Guzman, Nelson and Amare, Azmeraw T and Amini, Erfan and Ammar, Walid and Amoako, Yaw Ampem and Anber, Nahla Hamed and Andrei, Catalina Liliana and Androudi, Sofia and Animut, Megbaru Debalkie and Anjomshoa, Mina and Anlay, Degefaye Zelalem and Ansari, Hossein and Ansariadi, Ansariadi and Ansha, Mustafa Geleto and Antonio, Carl Abelardo T and Appiah, Seth Christopher Yaw and Aremu, Olatunde and ... and GBD 2017 Mortality Collaborators and Högskolan Dalarna and Akademin Utbildning, hälsa och samhälle and Medicinsk vetenskap
The Lancet, ISSN 0140-6736, 11/2018, Volume 392, Issue 10159, pp. 1684 - 1735
Journal Article